Application | Comment | Organism |
---|---|---|
medicine | since the Shumiya cataract rat model represents a new example of hereditary cholesterol deficiency-associated cataracts, it should be useful in the development of therapeutic and/or preventive measures for cataracts | Rattus norvegicus |
Cloned (Comment) | Organism |
---|---|
expression in Saccharomyces cerevisiae | Rattus norvegicus |
Protein Variants | Comment | Organism |
---|---|---|
D139N | reduced activity | Rattus norvegicus |
D139N/G189A/Q481R | induces cataracts in rats, produces only 39% of the lanosterol produced by wild-type | Rattus norvegicus |
H469-C472del | deletion allele, inactive | Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microsome | - |
Rattus norvegicus | - |
- |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-2,3-epoxysqualene | Rattus norvegicus | - |
lanosterol | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | P48450 | Shumiya cataract rat | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
lens | - |
Rattus norvegicus | - |
liver | - |
Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.0000429 | - |
cataractous Shumiya cataract rat | Rattus norvegicus |
0.000046 | - |
normal Shumiya cataract rat | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-2,3-epoxysqualene | - |
Rattus norvegicus | lanosterol | - |
? | |
2,3-oxidosqualene | - |
Rattus norvegicus | lanosterol | - |
? |
Synonyms | Comment | Organism |
---|---|---|
lanosterol synthase | - |
Rattus norvegicus |